Last edition
News about "JCR Pharmaceuticals "
JCR Pharmaceuticals secures its first international approval for Izcargo in the UAE, expanding access to its innovative blood-brain barrier-penetrating therapy for patients with Hunter syndrome and advancing rare disease treatment across the MENA region.
JCR Pharmaceuticals | 23/07/2026 | By News Bureau | 100
JCR Pharmaceuticals and Modalis to Develop Novel Gene Therapy
The purpose of this joint agreement is to conduct pre-clinical studies for the development of a new gene therapy for the undisclosed CNS disease by applying J-Brain Cargo®, JCR’s proprietary technology.
JCR Pharmaceuticals | 06/01/2025 | By Aishwarya | 526
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy